Dela Peña, Danilo B.
HRN: 14-47-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/13/2022
05/19/2022
PO
2.25g
Q6
Septic Shock
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes